Buy reiterated with a $196 price target after blowout Q2 2026 earnings, raised guidance, and 60%+ margins—read now.

Dine Brands Global reported Q2 2026 revenue above expectations, but EPS and adjusted EPS missed analyst estimates. Read more ...

OXLCM CEF's 8.25% term preferred offers high monthly income, strong protections, and improved security after OXLC ...

Everus Construction Group delivered a standout Q2 2026, with GAAP EPS of $1.64, beating estimates by 44% and driving the ...

Joby Aviation Q2 earnings: revenue beats on Blade growth as eVTOL certification advances; 2026 passenger target and raised ...

Schwab US Dividend Equity ETF may offer a safer way to keep diversified equity exposure amid macro risk. Click here to read ...

DIVO's selective covered call strategy targets only 20–30% of holdings, preserving capital appreciation. Read why DIVO ETF is ...

July 2026 was a flattish month for markets. On our machine learning forecasting models, we see asset class after asset class ...

Rigel Pharmaceuticals in-licensed Veppanu, a drug for the treatment of certain breast cancer patients, targeting a $1B market ...

High-yield bonds advanced in the second quarter as geopolitical tensions eased, helping stabilize energy prices and temper ...

The Madison Small Cap Fund returned 12.7% in Q2 2026, trailing benchmarks as tech and healthcare sectors surged. Read the ...

Braskem (BAK) faces default risk, leverage and liquidity stress, and likely equity wipeout amid industry headwinds. Read here ...